aging population

Three healthcare stocks—Pfizer (6.5% yield), Medtronic (3.6% yield with 48-year dividend streak), and Omega Healthcare (5.8% yield)—offer retirees attractive income streams amid aging demographics.

China's diabetes device market projected to nearly double from $7.19B in 2025 to $14.51B by 2034, driven by 118M patients and healthcare reforms.

With 73 million seniors expected by 2030, Intuitive Surgical's da Vinci robots positioned to capitalize on surging surgical demand through recurring consumable sales.

Global dermatology devices market projected to surge from $14.4B in 2024 to $25.6B by 2030, driven by rising skin cancer rates and aesthetic demand.

59 million American caregivers drive investment in aging-in-place healthcare stocks as 65+ population set to nearly double by 2060.

Healthcare Services Group executive sells $54K in shares following 107% one-year gain. Company reports strong 2025 results and authorizes new $75M buyback.

Click Holdings ($CLIK) reports 100% surge in senior care service hours and 34% growth in voucher cases, driven by Care U brand expansion and AI platforms.

Intuitive Surgical and DexCom positioned for long-term growth despite near-term competition, driven by aging populations and untapped market opportunities.

HCA Healthcare reports strong Q4 earnings with robust volume growth and optimistic 2026 guidance, though faces headwinds from insurance and state payment changes.

Shingles vaccine market poised for robust growth through 2036 driven by aging populations, vaccine adoption, and emerging candidates challenging market leader SHINGRIX.

Zostavax market set for sustained growth through 2035 driven by aging populations and expanded immunization programs, though tariff pressures spur manufacturing localization shifts.

Boston Scientific positioned to capitalize on global aging through AFib, chronic pain, and Parkinson's treatments; recent acquisitions boost stroke capabilities.

Healthcare transportation market projected to grow from $116.47B in 2026 to $155.26B by 2030, driven by aging population and home-based care expansion.

Intuitive Surgical faces near-term headwinds but maintains strong long-term growth potential through its dominant robotic surgery platform, structural competitive advantages, and expanding market opportunities.

HCA Healthcare reported strong Q4 2025 results with 6.7% revenue growth, but guided for slower 3.5% growth in 2026 due to ACA credit expiration and regulatory uncertainty.